Navigation Links
Stable Stroke Patients More Likely to Die From a Nonstroke Cardiovascular Event Than a Further Stroke
Date:5/15/2008

The REACH Registry reveals that 70% of deaths in the stable stroke

population were due to a cardiovascular event other than stroke

NICE, France, May 15 /PRNewswire/ -- New two-year data from the REACH Registry presented at the European Stroke Congress, highlight that among those who die after a stroke the vast majority (73%) will die from nonstroke cardiovascular (CV) events. The overall death rate is 4.45%, with 3.23% of these CV deaths from a nonstroke event.

The two-year data from the REACH Registry demonstrate that the risk of secondary ischemic events (including CV death) is very high in patients with previous stroke and/or TIA.

The REACH Registry has demonstrated that there is a high prevalence of atherothrombosis in more than one vascular bed: one-quarter of patients with coronary artery disease (CAD), two-fifths of patients with cerebrovascular disease (CVD) and three-fifths of patients with peripheral artery disease (PAD) also have atherothrombosis in other arterial locations. REACH Registry data also highlight the undertreatment of patients with CVD in the real-world setting. Improving ischemic risk management in these patients is required to prevent hospitalization and death.

Approximately 28% of patients in the REACH Registry have diagnosed CVD at baseline. About 40% of patients with CVD have polyvascular disease. Of the total CVD population at baseline: 71% suffered a prior stroke; 51% had a prior TIA; and, 20% had both.

Two-year data in the CVD population show high event rates for non-fatal stroke (5.9%). The risk of stroke, MI and CV death at two years was 11.5% for the total CVD population. Patients with a history of CVD are at considerable risk of major adverse cardiac events (MACE) and hospitalizations (>20% at two years).

"CVD patients are at high risk of recurrent stroke and other atherothrombotic events. Moreover the REACH Registry has shown that most of these stable stroke patients are a
'/>"/>

SOURCE REACH Registry
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4 5

Related biology technology :

1. Ranexa(R) Added to New ACC/AHA Guidelines on Unstable Angina/Non ST-Elevation Myocardial Infarction (UA/NSTEMI)
2. Biomatricas RNAstable(TM) Stabilizes RNA at Room Temperature
3. Altogen Biosystems Launches Custom Biotechnology Research Services: Generation of Stable Cell Lines and RNAi Cell Transfection Services
4. D-Pharm Completes Pre-IND Meeting With the FDA for Treatment of Acute Stroke With DP-b99
5. ThromboGenics Completes Patient Enrolment of MITI IV Trial, a Phase II Study Evaluating the Safety and Preliminary Efficacy of Microplasmin in the Treatment of Acute Stroke
6. Dendreon Announces Publication of Phase 1 Study Highlighting Immunologic and Clinical Activity of Lapuleucel-T (Neuvenge(R)) in Advanced Breast Cancer Patients
7. Cephalon Announces Positive Results from a Pivotal Study of FENTORA in Opioid-tolerant Patients with Non-cancer Breakthrough Pain
8. Vion Pharmaceuticals Completes Accrual of 85 Patients to its Pivotal Phase II Trial of Cloretazine(R) (VNP40101M) in Elderly AML
9. PNH Patients Treated with Soliris(TM) Experienced Dramatic Reduction in Blood Clots During Clinical Trials
10. Baxter to Launch GARDian(TM), a Groundbreaking Initiative That Helps Provide Continued Access to GAMMAGARD for Current Patients
11. New Study Findings Confirm CLEXANE(R)/LOVENOX(R) Long-Term Clinical Benefit in Patients Suffering From Acute Coronary Syndrome

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/24/2009)... , CALGARY and BLENHEIM, Ontario, Nov. 24 /PRN...unced today it is acquiring the assets of Hyland S... Ontario. The addition of Hyland Seeds will furthe...as the company anticipates the introduction of Sm...icide Tolerant Trait Technology in corn in 2012. T...
(Date:11/24/2009)... , ST. LOUIS, Nov. 24 /PRNewswire-FirstCall...ll be presenting at the NASDAQ OMX conference on T...5 AM US/CST. Interested parties may listen via liv... http://inve s tor.sig m a a ldrich.com/ . ... file. ,, About Sigma-Aldrich: Sigma-Aldr...
(Date:11/24/2009)... , REYKJAVIK, Iceland, Novemb...nc. (Nasdaq: DCGN ) today announced the approval o...uptcy Court for the District of Delaware,(the "Ban...y petition for,relief under Chapter 11 of the Unit...t. , The orders issued by the Bankruptcy ...
(Date:11/24/2009)... , SAN MATEO, Calif., Nov. 24 /PRNewswire-...biopharmaceutical company focused on developing an... announced today that Anthony DiTonno, President a...t at the 21st Annual Piper Jaffray Health Care Con...York Palace Hotel in New York, New York. ,, Mr...
Breaking Biology Technology:Dow AgroSciences Canada Announces Agreement to Acquire Hyland Seeds 2Dow AgroSciences Canada Announces Agreement to Acquire Hyland Seeds 3deCODE genetics, Inc. Announces Approval of First Day Motions by Bankruptcy Court 2deCODE genetics, Inc. Announces Approval of First Day Motions by Bankruptcy Court 3NeurogesX to Present at Piper Jaffray Health Care Conference 2NeurogesX to Present at Piper Jaffray Health Care Conference 3
...angamo BioSciences, Inc. (Nasdaq: SGMO ), the wo... finger DNA-binding proteins (ZFPs), announced tod...ges Explorations grant from the Bill & Melinda...vative global health research project conducted by...ses for In Vivo Treatment of HIV Infection." , ...
... Senesco Technologies, Inc. ("Senesco" or the "Co...al results for the three months ended March 31, 20...ed March 31, 2009 was $1,331,477, or $0.07 per sha...08 per share, for the three month period ended Mar...ily the result of a decrease in operating expenses...
...tion, Inc. (Nasdaq: MDVN ) today announced tha...anagement to discuss first quarter 2009 financial ...onday, May 11, 2009, at 4:30 p.m. Eastern Time. A...1, 2009 will be released after markets close on Ma...81-3376 from the U.S. or +1-719-325-4757 internati...
Other Biology Technology:Sangamo BioSciences Receives $100,000 Grand Challenges Explorations Grant for Innovative Global Health Research 2Sangamo BioSciences Receives $100,000 Grand Challenges Explorations Grant for Innovative Global Health Research 3Sangamo BioSciences Receives $100,000 Grand Challenges Explorations Grant for Innovative Global Health Research 4Senesco Technologies Reports Third Quarter Fiscal 2009 Financial Results 2Senesco Technologies Reports Third Quarter Fiscal 2009 Financial Results 3Senesco Technologies Reports Third Quarter Fiscal 2009 Financial Results 4Senesco Technologies Reports Third Quarter Fiscal 2009 Financial Results 5Senesco Technologies Reports Third Quarter Fiscal 2009 Financial Results 6Senesco Technologies Reports Third Quarter Fiscal 2009 Financial Results 7Medivation Announces First Quarter 2009 Financial Results Teleconference and Webcast on May 11, 2009 2
(Date:11/24/2009)... The Lupus Research Institute (LRI) today named 12...ng $3.6 million, recognize innovative work across ...ted for their creativity, novelty, and potential t..., treat, and cure the complex disease of systemic ...blished lupus researchers across the nation and in...
(Date:11/24/2009)... Stents that keep weakened and flabby arteries fro... six months, those stents are no longer needed -- ...necessary. Previously, doctors had no choice but t...of Tel Aviv University,s Department of Biomedical ...er platform that carries drugs where they,re neede...
(Date:11/24/2009)..., NEW YORK (November 24, 2009) -- T...oday a report revealing that the last remaining po...gnificantly due to the rising tide of poaching and... will help inform Russian officials of what needs ... world,s biggest cat. , The report ...
Breaking Biology News(10 mins):Lupus Research Institute announces 2009 novel research grants 2Lupus Research Institute announces 2009 novel research grants 3A coating for life 2Report shows dramatic decline in Siberian tigers 2InfoLogix Achieves Motorola Enterprise Mobility Validation 54799 1InfoLogix Achieves Motorola Enterprise Mobility Validation 54799 2InfoLogix Achieves Motorola Enterprise Mobility Validation 54799 3Uninsured Patients to Receive Free Surgeries Procedures 54795 1Uninsured Patients to Receive Free Surgeries Procedures 54795 2Uninsured Patients to Receive Free Surgeries Procedures 54795 3Uninsured Patients to Receive Free Surgeries Procedures 54795 4Hospitals Reduce Heart Attack Deaths 54790 1Hospitals Reduce Heart Attack Deaths 54790 2Hospitals Reduce Heart Attack Deaths 54790 3
...University’s Massey Cancer Center studying the int...s have identified interferon gamma as one of the s...he findings may help researchers develop tailored ... fight a number of cancers. Immunotherapy involves...cing an antibody or lymphocytes, or immunization w...
...of Genes & Development, Dr. Karlene Cimprich a...ed the minimal DNA structure sufficient to activat...re very excited about these results," says Dr. Cim...late the nature of the checkpoint activating struc...ontrol, quantitative and probe checkpoint signalin...
...eserve grapes could help prevent allergies and boo...nifer Rohn in Chemistry & Industry, the magazi... the wine-making process to produce healthier wine...a and other conditions in some people. , Mass-mar...are usually treated with sulphur dioxide to preven...
Other Biology News:Mechanisms involved with tumor relapse identified 2Grape expectations for healthier wine 2
... a Voltage Clamp, as a Current Clamp or as a Condu...ch applications. Performance in any one mode is as... This amazing instrument is made possible by very ...nal Processing (DSP) integrated circuit chips. Unt...
7500 Series ICP-MS ChemStation Upgrade from Agilent Technologies
... microRNA expression profiling and built on the fl...ynthesis platform. These microarrays are available...Profiling Service. Probe Content The Soil Nemat...matode microRNAs (114 unique mature sequences). Th...
...to the maintenance of appropriate levels of short-...erse as those involved in cellular metabolism, hea... modulation of cell surface receptors and ion chan...gnalling factors. The ubiquitin-proteasome pathwa...
Biology Products: